Pulse 探索 nav.journalClub 議論トレンド研究者ジャーナル

ホーム探索 nav.journalClub トレンド

⌘+K

An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy | Synapse

September 30, 2017Angewandte Chemie International Edition291 citations

An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy

View Full Paper

NTNikki A. ThieleOak Ridge National Laboratory VBVictoria BrownSimon Fraser University JKJames M. KellyCitigroup

Key Points

Key points are not available for this paper at this time.

Abstract

Ac TAT for the treatment of soft-tissue metastases.

AIに質問

Like

Bookmark

Share

View Full Paper

AIに質問

Like

Bookmark

Share

View Full Paper

Cite This Study

Thiele et al. (2017) studied this question.

synapsesocial.com/papers/6a013ade6018b8d0892dedea https://doi.org/10.1002/anie.201709532

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)2001 · 257 citations
2Lanthanide Complexes Based on a 1,7-Diaza-12-crown-4 Platform Containing Picolinate Pendants: A New Structural Entry for the Design of Magnetic Resonance Imaging Contrast Agents2008 · 100 citations
3Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease2013 · 114 citations
4Clinical Pharmacology of Trastuzumab2008 · 57 citations
5Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel2003 · 296 citations